ZymoGenetics is focused on the discovery, development, and early manufacture of therapeutic proteins. ZymoGenetics is a fully-integrated research and development organization with a broad range of skills and technologies, including scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, clinical development and operations, regulatory affairs, quality, drug formulation, process development and protein manufacturing.

Paratek Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry. Paratek's lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed in both oral tablet and intravenous formulations for use as a first-line monotherapy antibiotic for ABSSSI, CABP, urinary tract infections (UTI) and other serious community-acquired bacterial infections, particularly when antibiotic resistance is of concern to prescribing physicians. Omadacycline has received Qualified Infectious Disease Product (QIDP) designation by the U.S. Food and Drug Administration for both the oral and intravenous formulations in all three of these infectious disease categories. Paratek has Special Protocol Assessment agreements with the FDA for the phase 3 trials planned in ABSSSI and CABP.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Part of Pfizer Inc., Pfizer Anti-Infectives AB is a company headquartered in Sweden that provides professional, scientific and technical services.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Drugrecure ApS, a subsidiary of Savara, Inc., is a Danish company that provides health care services.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Seikagaku Corp. manufactures pharmaceuticals and medical devices with glycoconjugates; specifically, glycosaminoglycans (GAG) such as hyaluronic acid; as well as enzymes that act on GAG. It operates through the following segments: Pharmaceuticals and Limulus Amebocyte Lysate (LAL). The Pharmaceuticals segment develops and supplies intra-articular injections for improving joint functions, cross-linked hyaluronate hydrogel for knee osteoarthritis, opthalmic surgical aids, and surgical aids for endoscopic mucosal resection. The LAL segment manufactures and sells endotoxin-detecting reagents in Japan and overseas. The company was founded on June 2, 1947 and is headquartered in Tokyo, Japan.

Yantai Yinuoyi Biomedical Technology Co., Ltd., established on 2013-09-12, Business scope includes pharmaceutical products,Research on medical diagnostic reagents,Technology transfer and related technical consulting services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Andreas Hettich GmbH & Co. KG is a private company headquartered in Tuttlingen, Germany, with operations in Singapore, that manufactures industrial machinery. It was founded in 1904. Klaus-Günter Eberle is currently the CEO of the firm.\nThe company says this about itself: Since 1904, we have been driven by the commitment to facilitating our users‘ lives in their clinics and laboratories – with enhanced efficiency and ease of use. By successfully taking on this challenge we have become one of the world’s leading manufacturers of centrifuges. Today laboratory personnel value Hettich Centrifuges and Incubators because of their long service life, thoughtful design and ergonomics.

Jiaxing Changsheng Agricultural Development Co., Ltd., established on 2019-03-01, The scope of business includes the cultivation of primary edible agricultural products,Sales(Including online sales);Aquaculture,Sales(Including online sales);seedlings,trees,flowers,Planting and sales of Chinese herbal medicines;Livestock farming,Sales;seed(Packaged Seeds No Longer Divided),poultry eggs,pesticide,fertilizer(Does not contain hazardous chemicals and precursor chemicals),film,Wholesale and sales of agricultural machinery;Technological Development of Agricultural Technology,Technical Services,technical consulting,Achievement transfer;Snake domestication,reproduce,Sales;Sales of snake venom and snake products;Agritourism;Fruit and vegetable picking service;Import and export business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangzhou Daan Gene Co., Ltd., established on 1988-08-17, Business scope includes agricultural scientific research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Medical equipment rental;Development of Human Gene Diagnosis and Therapy Technology;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;R&D and application of cell technology;Human stem cell technology development and application;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;General machinery and equipment installation services;Special Equipment Repair;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Professional Design Services;software development;Machinery sales;Mechanical Parts,Parts sales;Engage in investment activities with own funds;Engineering Management Services;Refrigeration,Air Conditioning Equipment Manufacturing;General Equipment Repair;Auto New Car Sales;housing lease;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;pharmaceutical production;Inspection and testing service;Residential interior decoration;Import and export;Securities Investment Consulting;Construction Engineering Construction

Zhengzhou Renhong Pharmaceutical Technology Co., Ltd., established on 2015-11-20, The scope of business includes the development of medical technology,technology transfer;Sales of medical equipment,technical consulting,Technical Services;Technology development of computer hardware and software,technology transfer,technical consulting,Technical Services;Computer Data Processing Services;Computer System Integration Services.

Industry Academic Cooperation Foundation Hallym University is a private company headquartered in the South Korea. The firm provides office support services.

US Agriculture LLC provides investment services. It operates and manage farmland assets and portfolios, develop and implement farmland investment strategies, underwrite and acquire farmland assets across a variety of regions and crop types, develop and implement efficient and effective reporting processes, design and implement investment policies, develop and implement asset allocation strategies, create and implement tools for market and asset targeting, and create and implement portfolio optimization tools and processes. The company was founded in 2015 and is headquartered in Indianapolis, IN.

Spexis Ltd. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of respiratory therapeutics. The firm focuses on rare, chronic respiratory diseases (CRD) and chronic lung infections in cystic fibrosis. Its product pipeline includes ColiFin, Inhaled Murepavadin, Balixafortide (POL6326), OMPTA, EBX-002, and POL6014 (Lonodelestat). The company was founded by Daniel Obrecht and Jean-Pierre Obrecht in 1996 and is headquartered in Allschwil, Switzerland.

Part of GSK Plc, Beecham Group Plc is a British company located in Middlesex. The firm functions as an investment holding company. It was founded in 1928.\nThe company says this about itself: The principal activity Of the Company is the holding of Intercompany bans and receipt Of interest. The Company had previously been an investment holding company. The Company is a member Of the GlaxoSmithKline Group (the 'Group\"). The directors do not envisage any change to the nature of the business in the future,

Guiyang Yunyan Xichuang Pharmaceutical Technology Development Co., Ltd., established on 2004-06-16, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(traditional Chinese medicine,Western medicine,Health products,Chemical Products(Except for special items)and technology development of biological products,technology transfer.(The following blank)(2009year3moon30Daily photo change))

Guizhou Yibai Women's Pharmaceutical Co., Ltd., established on 2000-02-25, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(Production:hard capsule,tablet,Granules(Contains Chinese herbal extracts),Pills,soft capsule(Contains Chinese herbal extracts),Liquor and sales of medicines produced by the company(Operate within the validity period of the license);Sales of cosmetics and disinfection products;e-commerce.)